Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Studentbostäder i Norden AB in connection with its rights issue
Mandate

Vinge has advised Studentbostäder i Norden AB in connection with its rights issue

April 25, 2025 Capital Markets and Public M&A

Vinge has advised Studentbostäder i Norden AB (publ), a real estate company whose shares are listed on Nasdaq First North Premier Growth Market, in connection with an oversubscribed rights issue amounting to approximately SEK 145 million before deduction of transaction costs.

The new shares issued in the rights issue are expected to be admitted to trading on Nasdaq First North Premier Growth Market on or around 7 May 2025.

Studentbostäder i Norden AB (publ) owns, manages and develops student housing in long term partnerships with municipalities, counties and universities. The company’s shares are listed in Sweden on Nasdaq First North Premier Growth Market under the ticker STUDBO.

Vinge’s team consisted of Jesper Schönbeck, Joel Wahlberg, Benjamin Vafaeian, Johannes Akyol and Elias Kröger.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025